Yunnan Baiyao Group Co., Ltd. (000538)
SZSE
Closed
Sep 18, 2026
Day's Range
50.8552 wk Range
46.29Overview - 000538 - Yunnan Baiyao Group Co., Ltd.
Key Statistics
Valuation
Enterprise Value
75.70B
P/E (Trailing)
‪17.26‬
P/E (Forward)
‪15.56‬
PEG Ratio
‪15.56‬
Price / Sales (TTM)
‪2.15‬
Price / Book
‪2.19‬
EV / EBITDA
‪14.87‬
Profitability
Gross Margin
‪29.41%‬
Profit Margin
‪12.48%‬
Operating Margin
‪13.23%‬
Return on Assets
‪5.51%‬
Return on Equity
‪12.85%‬
Ownership
Shares Outstanding
1.78B
Float
721.32M
Held by Insiders
‪60.95%‬
Held by Institutions
‪12.02%‬
Price stats
Beta
‪0.09‬
50-Day Avg
‪50.56‬
200-Day Avg
‪53.36‬
Dividends
Payout Ratio
‪54.21%‬
Frequency
Annual
Analyst Consensus
11 analysts
Average price target
‪CN¥ 69.14‬Market Cap - 000538 - Yunnan Baiyao Group Co., Ltd.
Peers - 000538 - Yunnan Baiyao Group Co., Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on SZSE.
Profile Summary - 000538 - Yunnan Baiyao Group Co., Ltd.
About
Yunnan Baiyao Group Co., Ltd. is a significant player in the pharmaceutical industry, based in Yunnan, China. The company is renowned for its development and production of traditional Chinese medicine, particularly its flagship product, Baiyao, which is widely used for its hemostatic and wound healing properties.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
